These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 7664218

  • 1. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y.
    Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [Abstract] [Full Text] [Related]

  • 2. [Angiotensin-2 receptor blockade--new therapeutic approach to treatment of hypertension].
    Zimlichman R.
    Harefuah; 1996 Jul; 131(1-2):43-5. PubMed ID: 8854479
    [No Abstract] [Full Text] [Related]

  • 3. Losartan for hypertension.
    Med Lett Drugs Ther; 1995 Jun 23; 37(951):57-8. PubMed ID: 7783693
    [No Abstract] [Full Text] [Related]

  • 4. Angiotensin II receptor inhibition. A new therapeutic principle.
    Messerli FH, Weber MA, Brunner HR.
    Arch Intern Med; 1996 Sep 23; 156(17):1957-65. PubMed ID: 8823149
    [Abstract] [Full Text] [Related]

  • 5. Losartan in patients with renal insufficiency.
    de Zeeuw D, Gansevoort RT, de Jong PE.
    Can J Cardiol; 1995 Aug 23; 11 Suppl F():41F-44F. PubMed ID: 7664217
    [Abstract] [Full Text] [Related]

  • 6. [Medical angiotensin II-receptor blockade in hypertension and heart failure].
    van Zwieten PA, Lie KI.
    Ned Tijdschr Geneeskd; 1995 Jul 29; 139(30):1529-33. PubMed ID: 7675129
    [No Abstract] [Full Text] [Related]

  • 7. Global efficacy and tolerability of losartan, an angiotensin II subtype 1-receptor antagonist, in the treatment of hypertension.
    Mallion JM, Goldberg AI.
    Blood Press Suppl; 1996 Jul 29; 2():82-6. PubMed ID: 8913546
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin II antagonism: a new avenue of hypertension management.
    Gavras H.
    Blood Press Suppl; 1997 Jul 29; 1():42-6. PubMed ID: 9285108
    [Abstract] [Full Text] [Related]

  • 9. The diversified pharmacology of angiotensin II-receptor blockade.
    Timmermans PB, Smith RD.
    Blood Press Suppl; 1996 Jul 29; 2():53-61. PubMed ID: 8913541
    [Abstract] [Full Text] [Related]

  • 10. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
    Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, Julius S, Kjeldsen S, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H.
    Am J Hypertens; 1997 Jul 29; 10(7 Pt 1):705-13. PubMed ID: 9234823
    [Abstract] [Full Text] [Related]

  • 11. [Losartan and the LIFE-study. Antihypertensive treatment with AT1-receptor antagonist].
    Kjeldsen SE, Omvik P.
    Tidsskr Nor Laegeforen; 1996 Feb 10; 116(4):504-7. PubMed ID: 8644056
    [Abstract] [Full Text] [Related]

  • 12. The future role of losartan.
    Hansson L.
    J Hum Hypertens; 1995 Nov 10; 9 Suppl 5():S55-8. PubMed ID: 8583483
    [Abstract] [Full Text] [Related]

  • 13. [The first clinical experience in Italy with angiotensin II receptor antagonists: results of a multicenter study on the efficacy and tolerance in arterial hypertension].
    Trimarco B.
    Cardiologia; 1995 Dec 10; 40(12 Suppl 1):193-5. PubMed ID: 8998714
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of losartan.
    Goldberg A, Sweet C.
    Can J Cardiol; 1995 Aug 10; 11 Suppl F():27F-32F. PubMed ID: 7664215
    [Abstract] [Full Text] [Related]

  • 15. New angiotensin-II blocker.
    Lilley LL, Guanci R.
    Am J Nurs; 1996 Mar 10; 96(3):20. PubMed ID: 8607540
    [No Abstract] [Full Text] [Related]

  • 16. A new class of therapeutic agents: the angiotensin II receptor antagonists.
    Timmermans PB, Smith RD.
    Cardiologia; 1994 Dec 10; 39(12 Suppl 1):397-400. PubMed ID: 7634303
    [Abstract] [Full Text] [Related]

  • 17. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B.
    J Hum Hypertens; 1995 Nov 10; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [Abstract] [Full Text] [Related]

  • 18. [Angiotensin II receptor antagonists].
    Bornkessel B.
    Med Monatsschr Pharm; 1995 Jun 10; 18(6):148-51. PubMed ID: 7609710
    [No Abstract] [Full Text] [Related]

  • 19. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade?
    Brunner HR.
    J Hum Hypertens; 1995 Nov 10; 9(11):859-60. PubMed ID: 8583462
    [No Abstract] [Full Text] [Related]

  • 20. [Losartan, an angiotensin II receptor blocker: a new trend in cardiovascular chemotherapy].
    Krasnikova TL.
    Klin Med (Mosk); 1996 Nov 10; 74(3):17-21. PubMed ID: 8926692
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.